Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database.

ABSTRACT:

Background

As prostaglandin medications, crucial in glaucoma treatment, become more widely used, their local adverse events are increasingly observed.

Objectives

To evaluate the common adverse events of four clinically commonly used prostaglandin F (FP) receptor agonists in the treatment of glaucoma in the Food and Drug Administration Adverse Event Reporting System (FAERS) database.

Design

We screened and analyzed the generic and brand names of latanoprost, bimatoprost, travoprost, and tafluprost in the FAERS database and summarized and cleaned the baseline information of subjects receiving the above-mentioned drugs.

Methods

Perform descriptive statistical analysis on the baseline information of subjects using the drugs. Conduct disproportionality analysis of d

SUBMITTER: Wu SN 

PROVIDER: S-EPMC11487502 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature